Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Biliary Tract Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02115542
What this trial is testing

Single Agent Regorafenib in Refractory Advanced Biliary Cancers

Who this might be right for
Cancer of the Bile Duct
H. Lee Moffitt Cancer Center and Research Institute 39
Testing effectiveness (Phase 2)Study completedNCT03260712
What this trial is testing

Pembrolizumab in Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerMetastatic CancerAdvanced Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 50
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Ended earlyNCT05346484
What this trial is testing

CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors

Who this might be right for
Solid TumorSolid CarcinomaSolid Tumor, Adult+4 more
Imugene Limited 66
Not applicableUnknownNCT04337333
What this trial is testing

Two-in-one Covered and Uncovered Metal Stent

Who this might be right for
Extrahepatic Bile Duct CancerPancreatic CancerLymph Node Metastases+1 more
Ajou University School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT03110328
What this trial is testing

Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes

Who this might be right for
Biliary Tract Cancer
Samsung Medical Center 33
Large-scale testing (Phase 3)Study completedNCT02853474
What this trial is testing

Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy

Who this might be right for
Gastric CancerPancreas CancerBile Duct Cancer+2 more
Centre Oscar Lambret 480
Testing effectiveness (Phase 2)UnknownNCT05417230
What this trial is testing

RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2

Who this might be right for
Biliary Tract Cancer
Jiangsu Cancer Institute & Hospital 29
Testing effectiveness (Phase 2)Study completedNCT04722133
What this trial is testing

Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy

Who this might be right for
HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
Yonsei University 36
Not applicableStudy completedNCT03222258
What this trial is testing

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

Who this might be right for
Stage IV Breast CancerStage IV Pancreatic CancerStage IV Colon Cancer+9 more
Seoul National University Hospital 444
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Early research (Phase 1)Ended earlyNCT04178460
What this trial is testing

Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Who this might be right for
Gastric CancerTriple Negative Breast CancerBiliary Tract Carcinoma+1 more
Zai Lab (Shanghai) Co., Ltd. 60
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05123482
What this trial is testing

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Who this might be right for
Breast CancerBiliary Tract CarcinomaOvarian Cancer+2 more
AstraZeneca 460
Testing effectiveness (Phase 2)Active Not RecruitingNCT07635290
What this trial is testing

Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

Who this might be right for
Previously Treated, AdvancedBiliary Tract Cancers
West China Hospital 26
Testing effectiveness (Phase 2)Ended earlyNCT02992340
What this trial is testing

Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC

Who this might be right for
Biliary Tract Cancer
ASLAN Pharmaceuticals 204
Early research (Phase 1)Study completedNCT02443324
What this trial is testing

Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

Who this might be right for
Gastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionNon-small Cell Lung Cancer+2 more
Eli Lilly and Company 175
Not applicableActive Not RecruitingNCT04584008
What this trial is testing

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Who this might be right for
Biliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more
Peking University 600
Next Page